Epidyolex Archives -

Patients in Wales with a rare disease that causes epilepsy will be the first in the UK to

Wales is first UK country to fund GW’s Epidyolex for tuberous sclerosis

https://pharmaphorum.com/news/wales-is-first-uk-country-to-fund-gws-epidyolex-for-tuberous-sclerosis/

GW Pharmaceuticals’ Epidyolex has been approved in the EU for a third epilepsy indication, giving a boost for

Jazz lifted by third EU approval for GW Pharma’s Epidyolex

https://pharmaphorum.com/news/jazz-lifted-by-third-eu-approval-for-gw-pharmas-epidyolex/

The UK’s GW Pharma has insisted there will be no repeat of the controversy seen with cystic fibrosis

GW confident epilepsy drug will get NHS funding despite NICE rejection

https://pharmaphorum.com/news/no-repeat-of/

Epidyolex